+
With Actis acquiring Rx Propellant, plans a $200 mn investment
Real Estate

With Actis acquiring Rx Propellant, plans a $200 mn investment

Actis, a global investment firm focused on private equity, energy, infrastructure, and real estate assets, has acquired Rx Propellant, a real estate solutions provider to tenants in life sciences and related sectors across India.

Actis plans to invest $200 million into a buy and build program, targeting greenfield and brownfield projects, focusing on sustainability. Rx Propellant will focus on thriving life sciences groups in cities, including Hyderabad, Bengaluru and Mumbai.

Partner and Head of real estate at Actis, Brian Chinappi, said that the life sciences sector in India is already of global strategic importance, as seen during the Covid-19 pandemic. It has restricted significant growth from local and global issues.

Recently, Actis announced that it had completed fundraising for Actis Asia Real Estate Fund 2. The $700 million funds show LP fund and co-investment commitments, with co-investment opportunities expected to deliver up to $1 billion of investable capital during the funding life period.

The fund will allocate capital to invest in the real estate sector, promoting a new economy, focusing on China, Korea, India, South-East Asia, and Vietnam.

Rx Propellant is invested in the development and marketing of several real estate projects that are in the design-development stage across Hyderabad and Bengaluru, focusing on the life sciences sector, aggregating over 3 million sq ft.

Image Source

Also read: Actis raises over $4.7 bn, plans $850 investment in India

Actis, a global investment firm focused on private equity, energy, infrastructure, and real estate assets, has acquired Rx Propellant, a real estate solutions provider to tenants in life sciences and related sectors across India. Actis plans to invest $200 million into a buy and build program, targeting greenfield and brownfield projects, focusing on sustainability. Rx Propellant will focus on thriving life sciences groups in cities, including Hyderabad, Bengaluru and Mumbai. Partner and Head of real estate at Actis, Brian Chinappi, said that the life sciences sector in India is already of global strategic importance, as seen during the Covid-19 pandemic. It has restricted significant growth from local and global issues. Recently, Actis announced that it had completed fundraising for Actis Asia Real Estate Fund 2. The $700 million funds show LP fund and co-investment commitments, with co-investment opportunities expected to deliver up to $1 billion of investable capital during the funding life period. The fund will allocate capital to invest in the real estate sector, promoting a new economy, focusing on China, Korea, India, South-East Asia, and Vietnam. Rx Propellant is invested in the development and marketing of several real estate projects that are in the design-development stage across Hyderabad and Bengaluru, focusing on the life sciences sector, aggregating over 3 million sq ft. Image Source Also read: Actis raises over $4.7 bn, plans $850 investment in India

Related Stories

Gold Stories

Next Story
Infrastructure Urban

Beyond Building Faster

India’s cities are expanding at an unprecedented pace, bringing new infrastructure and development opportunities while also intensifying challenges around mobility, public spaces, liveability and supporting infrastructure. The question, therefore, is not simply whether India can build faster, but whether it can build cities that work better.At a CW webinar, Are We Designing Better Cities – or Just Building Faster?, moderator Ar. Samir Shaikh, Founding Principal, AR&UD Studio, brought together perspectives from design, development, master planning and technology...To read the full artic..

Next Story
Infrastructure Transport

Risk is the Roadblock

For an industry often described as capital-intensive, India’s roads and highways sector faces an interesting paradox: Capital is available, but not every form of capital is willing to take every kind of risk.The discussion on Financing Roads & Highways in a Capital-Constrained Era, moderated by Suneet K Maheshwari, Managing Partner, Udvik Infra, and Independent Board Director, brought together Pratik Panwala, Vice President, Investments, NIIFL; Vishal Gupta, Senior Vice President - PA&SF, SBI Capital Markets; Sandeep Upadhyay, Managing Director - Infrastructure Advisory, Centrum Capi..

Next Story
Infrastructure Urban

When the Clause Bars Damages

In large-scale infrastructure and construction projects, delays are often an inevitable reality. To shield themselves from financial liabilities arising out of project prolongations, employers – particularly government entities and public-sector undertakings (PSUs) – frequently incorporate standard ‘No Damage for Delay’ or ‘No Liability’ clauses. These clauses aim to restrict the contractor's remedy solely to an extension of time (EOT), barring any monetary claims for extra overheads, idling costs or lost profits.Origin and relevanceUnderstanding the nature, enforceability and judi..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

SPECIAL OFFER
QR Code